Arrowhead Research | ARWR - Pre Tax Profit

Stock Price
64.52
Daily Change
-0.12 -0.19%
Monthly
-1.78%
Yearly
218.77%
Q1 Forecast
67.19

Arrowhead Research reported $28.27M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agios Pharmaceuticals USD -103.43M 8.59M Sep/2025
Alnylam Pharmaceuticals USD 238.97M 274.33M Sep/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Incyte USD 482.31M 75.7M Sep/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
Ligand Pharmaceuticals USD 141.14M 102M Sep/2025
Merck USD 6.74B 22M Sep/2025
Moderna USD -187M 631M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Sarepta Therapeutics USD -194.05M 347.69M Sep/2025
TG Therapeutics USD 25.91M 5.01M Sep/2025
Ultragenyx Pharmaceutical USD -179.54M 65.54M Sep/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025
Xencor USD -6.03M 25.05M Sep/2025